Archive

• Axa IM Alts backs preterm birth reduction tech firm

  18 July 2024

  Investing $14m in Novocuff as part of Series A funding round

• AXA IM Alts invests $25m in biopharmaceutical company Vedanta Biosciences

  26 April 2023

  As part of drive to fund affordable and innovative solutions to gastrointestinal diseases and malnutrition

• Axa commits $200m to affiliate's PE healthcare strategy

  04 April 2022

  Axa IM Alts targets $500m commitments